Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-20

Clinical Trial Update: Indocyanine Green for Solid Tumors [Phase 1]

View source ↗

Summary

This clinical trial update notes a completed Phase 1 study of indocyanine green for solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: University of Pennsylvania | Conditions: Solid Tumor, Neoplasms | Phase 1 | Status: COMPLETED